28A3 Campling, Barbara - Thomas Jefferson University - Thomas Jefferson University
Dr. Campling

Barbara Campling, MD

Contact Dr. Campling

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests
  2. Acute activation, desensitization and smoldering activation of human acetylcholine receptors
  3. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
  4. Choline transporter-like protein 4 (CTL4) links to non-neuronal acetylcholine synthesis
  5. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field Radiotherapy and concurrent chemotherapy
  6. Spontaneous smoking cessation before lung cancer diagnosis
  7. The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
  8. The problem of platinum resistance
  9. A population-based study of lung carcinoma in Pennsylvania: Comparison of Veterans Administration and Civilian Populations
  10. Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer
  11. Topotecan in small cell lung cancer: First or second line?
  12. Clinical implications of p53 mutations in lung cancer.
  13. Clinical implication of p53 mutation in lung cancer
  14. Therapy and disease concepts: The history (and future?) of antimony in cancer
  15. Constitutive activation of Met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival
  16. Clinical and molecular features of small cell lung cancer
  17. The role of single-agent docetaxel as second-line treatment for advanced non-small-cell lung cancer
  18. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: Correlation of protein levels with drug response and messenger RNA levels
  19. Enhanced anti-cancer activities of some derivatives of titanocene dichloride
  20. Simultaneous quantitation of topoisomerase II α and β isoform mRNAs in lung tumor cells and normal and malignant lung tissue